Extracardiovascular toxic effects of drugs used in cardiology
Zennaro, R.G.
Cardiologia 40(12 Suppl 1: 99-104
1995
ISSN/ISBN: 0393-1978 PMID: 8998789 Document Number: 451883
Document emailed within 1 workday
Related Documents
Iarussi, D.; Gualtieri, S.; Tedesco, M.A.; Iacono, A. 1995: Cardiovascular toxic effects of drugs not used in cardiology Cardiologia 40(12 Suppl 1: 105-111Anibaldi, A.; Santin, L.; Scalercio, A.; Stella, S. 1982: Toxic effects of drugs on the cardiovascular system Minerva Pediatrica 34(5): 215-224
Broor, S.L.; Wig, N.N.; Wahi, P.L. 1973: A study of toxic effects of certain psychotropic drugs with special emphasis on their cardiotoxicity Journal of the Association of Physicians of India 21(9): 737-742
Czajkowska, T.; Krysiak, B.; Popińska, E. 1987: Experimental studies of toxic effects of 1,3,5-trioxane and 1,3-dioxolane. I. Acute toxic effect Medycyna Pracy 38(3): 184-190
Czajkowska, T.; Krysiak, B. 1987: Experimental studies of the toxic effects of 1,3,5-trioxane and 1,3-dioxolane. II. Cumulation of toxic effect Medycyna Pracy 38(4): 244-249
Halawa, B.; Mazurek, W. 1980: Interactions between drugs used in cardiology Wiadomosci Lekarskie 33(7): 533-538
Mühlberger, V.; Klein, W.; Mlczoch, J.; Probst, P. 1996: Quality assurance in invasive and interventional cardiology in Austria in 1994. Commissioned by the Interventional Cardiology Working Group of the Austrian Cardiology Society Zeitschrift für Kardiologie 85(9): 647-655
Adams, H.R. 1986: New perspectives in cardiology: pharmacodynamic classification of antiarrhythmic drugs Journal of the American Veterinary Medical Association 189(5): 525-532
Bai, R.; Liu, N.; Hu, D.; Ma, C. 2014: Urgent action is needed to change the status of "orphan drugs" in cardiology in China Zhonghua Xin Xue Guan Bing Za Zhi 42(7): 543-544
Mareev, V.I. 2006: Application of aspirin and other non-steroid anti-inflammatory drugs in cardiology. Cardiologist's expert opinion Eksperimental'naia i Klinicheskaia Gastroenterologiia 2: 10-12
Veggeland, T. 1996: Improved information on drugs to patients. A project with a pharmacist in the therapeutic team at a cardiology department Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 116(16): 1901-1903
Zafrani, E.S. 1983: Drugs, toxic substances and subhepatic veins Gastroenterologie Clinique et Biologique 7(11): 894-897
Tampalini, L. 1972: Complications due to toxic factors (drugs and other substances) during pregnancy Minerva Pediatrica 24(40): 1979-2000
Goicoechea, F.J.; Jelliffe, R.W. 1974: Computerized dosage regimens for highly toxic drugs American Journal of Hospital Pharmacy 31(1): 67-71
Greĭser, A.E.; Fomin, L.M. 1972: The electrocardiogram in the treatment of toxic goiter patients with thyrostatic drugs Klinicheskaia Meditsina 50(8): 95-98
Marek, J. 1985: On the non-specific antiinflammatory effects of other-than-antirheumatic drugs. Psychotropic drugs, inflammation and antiinflammatory drugs International Journal of Tissue Reactions 7(6): 475-504
Lequime, J. 1985: The Belgian Society of Cardiology and its role in the development of international cardiology Acta Cardiologica 40(5): 501-510
Galván Montiel, O. 1996: Guidelines and recommendations of the Mexican Society of Cardiology for training in cardiology Archivos del Instituto de Cardiologia de Mexico 66(3): 288-290
Hutters, L.; Andreasen, P.B. 1978: Toxic hepatitis after halothane. 98 cases reported to the Danish Board on Adverse Reactions to Drugs Ugeskrift for Laeger 140(14): 798-799
Bunch, S.E.; Conway, M.B.; Center, S.A.; Castleman, W.L.; Baldwin, B.H.; Hornbuckle, W.E.; Tennant, B.C. 1987: Toxic hepatopathy and intrahepatic cholestasis associated with phenytoin administration in combination with other anticonvulsant drugs in three dogs Journal of the American Veterinary Medical Association 190(2): 194-198